Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
gastroesophageal adenocarcinoma, first line therapy, her2 + gastric cancer, pdl-1, metastases, gea, her2-positive, pd-l1 positive, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 912141
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.